Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02481154 |
Title | Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Institut de Recherches Internationales Servier |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCLA Oncology Center | Los Angeles | California | 90024 | United States | Details | |
University of California San Francisco | San Francisco | California | 94143 | United States | Details | |
University of Miami | Miami | Florida | 33136 | United States | Details | |
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Duke University Medical Center | Durham | North Carolina | 27710 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
UT Southwestern Medical Center | Dallas | Texas | 77030 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 75390 | United States | Details |